Brain-derived Neurotrophic Factor Promotes Survival and Chemoprotection of Human Neuroblastoma Cells*

Brain-derived neurotrophic factor (BDNF) promotes neuronal survival and protection against neuronal damage. We addressed whether BDNF might promote survival and chemoprotection in neuroblastoma (NB) using a drug-sensitive human NB cell line. All-trans-retinoic acid (ATRA) induces a striking phenotypic differentiation of NB1643 cells, and exogenous BDNF treatment promotes survival of these differentiated cells. ATRA induces TRKB expression, and exogenous BDNF stimulates both autophosphorylation of TRKB and induction of the immediate early gene, FOS, in these cells.BDNF mRNA is expressed in NB1643 cells. Because the time course of TRKB induction closely parallels phenotypic differentiation of these cells, it seems probable that ATRA induces differentiation of NB1643 cells by establishing an autocrine loop involving BDNF and TRKB. Exogenous BDNF treatment resulted in a further increase in neurite outgrowth, which again suggests that an autocrine loop is involved in differentiation of NB1643 cells in response to ATRA. We then tested whether BDNF might afford drug resistance in NB and found that BDNF does indeed protect in this NB model against cisplatin, a DNA-damaging agent actually used in the treatment of NB.

[1]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[2]  Xiao-Dan Zhu,et al.  Brain-derived Neurotrophic Factor Induces Phosphorylation of Fibroblast Growth Factor Receptor Substrate 2* , 1999, The Journal of Biological Chemistry.

[3]  I. Lax,et al.  Binding of Shp2 Tyrosine Phosphatase to FRS2 Is Essential for Fibroblast Growth Factor-Induced PC12 Cell Differentiation , 1998, Molecular and Cellular Biology.

[4]  C. Thiele,et al.  Activation of Three Distinct RXR/RAR Heterodimers Induces Growth Arrest and Differentiation of Neuroblastoma Cells* , 1997, The Journal of Biological Chemistry.

[5]  D. Bar-Sagi,et al.  A Lipid-Anchored Grb2-Binding Protein That Links FGF-Receptor Activation to the Ras/MAPK Signaling Pathway , 1997, Cell.

[6]  M. Barbacid,et al.  TrkB Signaling Is Required for Postnatal Survival of CNS Neurons and Protects Hippocampal and Motor Neurons from Axotomy-Induced Cell Death , 1997, The Journal of Neuroscience.

[7]  M. Radeke,et al.  Signal Transduction Mediated by the Truncated trkB Receptor Isoforms, trkB.T1 and trkB.T2 , 1997, The Journal of Neuroscience.

[8]  P. Houghton,et al.  Efficacy of systemic administration of irinotecan against neuroblastoma xenografts. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[9]  A. Davies,et al.  Timing of neuronal death in trkA, trkB and trkC mutant embryos reveals developmental changes in sensory neuron dependence on Trk signalling. , 1996, Development.

[10]  S. Bates,et al.  Brain-derived neurotrophic factor protects neuroblastoma cells from vinblastine toxicity. , 1996, Cancer research.

[11]  R. Stephens,et al.  Deletion of a conserved juxtamembrane sequence in Trk abolishes NGF-promoted neuritogenesis , 1995, Neuron.

[12]  F. Hefti,et al.  Differential regulation of catalytic and non-catalytictrkB messenger RNAs in the rat hippocampus following seizures induced by systemic administration of kainate , 1995, Neuroscience.

[13]  E. Nånberg,et al.  Transfection of TRK-A into human neuroblastoma cells restores their ability to differentiate in response to nerve growth factor. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[14]  H. Rohrer,et al.  Retinoic Acid-Mediated Increase in TrkA Expression Is Sufficient to Elicit NGF-Dependent Survival of Sympathetic Neurons , 1995, Molecular and Cellular Neuroscience.

[15]  K. Matsumoto,et al.  Expression of brain-derived neurotrophic factor and p145TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells. , 1995, Cancer research.

[16]  T. Pawson,et al.  A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides , 1995, Current Biology.

[17]  G. Cooper,et al.  Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. , 1995, Science.

[18]  G. Yancopoulos,et al.  A BDNF autocrine loop in adult sensory neurons prevents cell death , 1995, Nature.

[19]  A. Ross,et al.  TrkA neurogenic receptor regulates differentiation of neuroblastoma cells. , 1995, Oncogene.

[20]  N. Papadopoulos,et al.  An improved fluorescence assay for the determination of lymphocyte-mediated cytotoxicity using flow cytometry. , 1994, Journal of immunological methods.

[21]  Ireland Cm,et al.  Establishment of an in vitro model for cisplatin resistance in human neuroblastoma cell lines. , 1994 .

[22]  Michael J. Fry,et al.  Phosphatidylinositol-3-OH kinase direct target of Ras , 1994, Nature.

[23]  K. Onodera,et al.  Neurite outgrowth of PC12 cells is suppressed by wortmannin, a specific inhibitor of phosphatidylinositol 3-kinase. , 1994, The Journal of biological chemistry.

[24]  R. Klein.  Role of neurotrophins in mouse neuronal development , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  R. Martin,et al.  CARE-LASS (calcein-release-assay), an improved fluorescence-based test system to measure cytotoxic T lymphocyte activity. , 1994, Journal of immunological methods.

[26]  P Chambon,et al.  The retinoid signaling pathway: molecular and genetic analyses. , 1994, Seminars in cell biology.

[27]  A. Ullrich,et al.  Neuronal differentiation signals are controlled by nerve growth factor receptor/Trk binding sites for SHC and PLC gamma. , 1994, The EMBO journal.

[28]  R. Stephens,et al.  A Trk nerve growth factor (NGF) receptor point mutation affecting interaction with phospholipase C-gamma 1 abolishes NGF-promoted peripherin induction but not neurite outgrowth. , 1994, The Journal of biological chemistry.

[29]  M. Mattson,et al.  NT-3 and BDNF protect CNS neurons against metabolic/excitotoxic insults , 1994, Brain Research.

[30]  M E Greenberg,et al.  Requirement for BDNF in activity-dependent survival of cortical neurons. , 1994, Science.

[31]  M. Barbacid,et al.  Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene , 1994, Nature.

[32]  T. Pawson,et al.  Trk receptors use redundant signal transduction pathways involving SHC and PLC-γ1 to mediate NGF responses , 1994, Neuron.

[33]  T. Hunter,et al.  Identification of TrkB autophosphorylation sites and evidence that phospholipase C-gamma 1 is a substrate of the TrkB receptor. , 1994, The Journal of biological chemistry.

[34]  A. Nakagawara,et al.  Expression and function of TRK-B and BDNF in human neuroblastomas , 1994, Molecular and cellular biology.

[35]  K. Hauser,et al.  Morphine does not affect astrocyte survival in developing primary mixed-glial cultures. , 1993, Brain research. Developmental brain research.

[36]  E. Bogenmann,et al.  Expression of trkA cDNA in neuroblastomas mediates differentiation in vitro and in vivo , 1993, Molecular and cellular biology.

[37]  A. Ullrich,et al.  Identification of Trk binding sites for SHC and phosphatidylinositol 3'-kinase and formation of a multimeric signaling complex. , 1993, The Journal of biological chemistry.

[38]  N. Neff,et al.  A rapid fluorometric assay to measure neuronal survival in vitro , 1993, Journal of Neuroscience Methods.

[39]  M. Barbacid,et al.  Targeted disruption of the trkB neurotrophin receptor gene results in nervous system lesions and neonatal death , 1993, Cell.

[40]  D. Kaplan,et al.  Induction of TrkB by retinoic acid mediates biologic responsiveness to BDNF and differentiation of human neuroblastoma cells , 1993, Neuron.

[41]  M. Borrello,et al.  trk and ret proto‐oncogene expression in human neuroblastoma specimens: High frequency of trk expression in non‐advanced stages , 1993, International journal of cancer.

[42]  T. Hökfelt,et al.  Characterization of glial trkB receptors: differential response to injury in the central and peripheral nervous systems. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[43]  C. Dominici,et al.  Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis. , 1993, Cancer research.

[44]  D. Kaplan,et al.  SNT, a differentiation-specific target of neurotrophic factor-induced tyrosine kinase activity in neurons and PC12 cells , 1993, Molecular and cellular biology.

[45]  A. Cantor,et al.  Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. , 1993, The New England journal of medicine.

[46]  D. Stram,et al.  Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas. , 1993, Journal of the National Cancer Institute.

[47]  A. Ullrich,et al.  Tyrosine 785 is a major determinant of Trk‐‐substrate interaction. , 1993, The EMBO journal.

[48]  O. Lindvall,et al.  Increased production of the TrkB protein tyrosine kinase receptor after brain insults , 1993, Neuron.

[49]  T. Hökfelt,et al.  Increased levels of trkB mRNA and trkB protein-like immunoreactivity in the injured rat and cat spinal cord. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[50]  M. Barbacid,et al.  Nerve growth factor mediates signal transduction through trk homodimer receptors , 1992, Neuron.

[51]  Alan R. Saltiel,et al.  Activation of phosphatidylinositol-3 kinase by nerve growth factor involves indirect coupling of the trk proto-oncogene with src homology 2 domains , 1992, Neuron.

[52]  M. Barbacid,et al.  The trkB tyrosine protein kinase is a receptor for neurotrophin-4 , 1992, Neuron.

[53]  M. Arima,et al.  Inverse relationship between trk expression and N-myc amplification in human neuroblastomas. , 1992, Cancer research.

[54]  M. Barbacid,et al.  trkC, a new member of the trk family of tyrosine protein kinases, is a receptor for neurotrophin-3 , 1991, Cell.

[55]  M. Barbacid,et al.  The trkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-3 , 1991, Cell.

[56]  J. Bishop,et al.  Nerve growth factor rapidly stimulates tyrosine phosphorylation of phospholipase C-gamma 1 by a kinase activity associated with the product of the trk protooncogene. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[57]  H. Rohrer,et al.  Retinoic acid induces NGF-dependent survival response and high-affinity NGF receptors in immature chick sympathetic neurons. , 1991, Development.

[58]  T. Hunter,et al.  The neurotrophic factors brain-derived neurotrophic factor and neurotrophin-3 are ligands for the trkB tyrosine kinase receptor , 1991, Cell.

[59]  P. Distefano,et al.  trkB encodes a functional receptor for brain-derived neurotrophic factor and neurotrophin-3 but not nerve growth factor , 1991, Cell.

[60]  D. Kaplan,et al.  The trk proto-oncogene product: a signal transducing receptor for nerve growth factor. , 1991, Science.

[61]  M. Barbacid,et al.  The trk proto-oncogene encodes a receptor for nerve growth factor , 1991, Cell.

[62]  D. Kaplan,et al.  Tyrosine phosphorylation and tyrosine kinase activity of the trk proto-oncogene product induced by NGF , 1991, Nature.

[63]  T. Hunter,et al.  trkB, a neural receptor protein-tyrosine kinase: evidence for a full-length and two truncated receptors , 1991, Molecular and cellular biology.

[64]  M. Barbacid,et al.  Expression of the tyrosine kinase receptor gene trkB is confined to the murine embryonic and adult nervous system. , 1990, Development.

[65]  M. Barbacid,et al.  The trkB tyrosine protein kinase gene codes for a second neurogenic receptor that lacks the catalytic kinase domain , 1990, Cell.

[66]  M. Israel,et al.  Human neuroblastoma tumor cell lines correspond to the arrested differentiation of chromaffin adrenal medullary neuroblasts. , 1990, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[67]  M. Barbacid,et al.  Molecular and biochemical characterization of the human trk proto-oncogene , 1989, Molecular and cellular biology.

[68]  M. Davy,et al.  Disposition of unchanged cisplatin in patients with ovarian cancer , 1987, Clinical pharmacology and therapeutics.

[69]  D. Melton,et al.  Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. , 1984, Nucleic acids research.

[70]  W. B. Butler,et al.  Preparing nuclei from cells in monolayer cultures suitable for counting and for following synchronized cells through the cell cycle. , 1984, Analytical biochemistry.

[71]  H. Varmus,et al.  Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. , 1984, Science.

[72]  R. Ross,et al.  Coordinate morphological and biochemical interconversion of human neuroblastoma cells. , 1983, Journal of the National Cancer Institute.

[73]  T. Triche,et al.  Neuroblastoma and the differential diagnosis of small-, round-, blue-cell tumors. , 1983, Human pathology.

[74]  LA Greene,et al.  Nerve growth factor prevents the death and stimulates the neuronal differentiation of clonal PC12 pheochromocytoma cells in serum-free medium , 1978, The Journal of cell biology.